tiprankstipranks
NervGen Pharma (NGEN)
NASDAQ:NGEN
US Market
NGEN
NervGen Pharma
RESEARCH TOOLSreports
Want to see NGEN full AI Analyst Report?

NervGen Pharma (NGEN) Income Statement

93 Followers

NervGen Pharma Income Statement

Last quarter (Q4 2025), NervGen Pharma's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q4, NervGen Pharma's net income was C$-31.70M. See NervGen Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Dec 22Dec 21
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ 0.00C$ -58.23KC$ -109.40KC$ -84.92KC$ -33.70K
Operating Expenses
C$ 25.08MC$ 17.27MC$ 13.30MC$ 16.90MC$ 10.09M
Depreciation and Amortization
C$ 55.80KC$ 58.23KC$ 109.40KC$ 84.92KC$ 33.70K
EBITDA
C$ -5.65MC$ -16.62MC$ -16.78MC$ -14.82MC$ -10.03M
Operating Income
C$ -25.08MC$ -17.33MC$ -13.41MC$ -16.99MC$ -10.13M
Other Income/Expenses
C$ -19.04MC$ 643.55KC$ -3.47MC$ 1.70MC$ 66.92K
Pretax Income
C$ -44.12MC$ -16.68MC$ -16.89MC$ -15.29MC$ -10.06M
Net Income
C$ -44.12MC$ -16.68MC$ -16.89MC$ -15.29MC$ -10.06M
Per Share Metrics
Basic EPS
C$ -0.61C$ -0.25C$ -0.28C$ -0.29C$ -0.26
Diluted EPS
C$ -0.61C$ -0.25C$ -0.28C$ -0.29C$ -0.26
Weighted Average Shares Outstanding
 72.33M 67.32M 59.29M 52.65M 39.29M
Weighted Average Shares Outstanding (Diluted)
 72.33M 67.32M 59.29M 52.65M 39.29M
Currency in CAD

NervGen Pharma Earnings and Revenue History